公开(公告)号：US20210323938A1

公开(公告)日：2021-10-21

申请号：US17234660

申请日：2021-04-19

Applicant: H. LUNDBECK A/S

Inventor： Cheryl A. GRICE ,  Kurt G. GRIMM ,  Todd K. JONES ,  Giuseppe GUERCIO

IPC: C07D295/02

Abstract: Described herein is the manufacture of MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate including salts thereof.

公开(公告)号：US20240158360A1

公开(公告)日：2024-05-16

申请号：US18325798

申请日：2023-05-30

Applicant: H. Lundbeck A/S

Inventor： Cheryl A. GRICE ,  Kurt G. GRIMM ,  Todd K. JONES ,  Giuseppe GUERCIO

IPC: C07D295/02 ,  C07D295/023

CPC classification number: C07D295/02 ,  C07D295/023 ,  C07B2200/13

Abstract: Described herein is the manufacture of MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate including salts thereof.

公开(公告)号：US20230312499A1

公开(公告)日：2023-10-05

申请号：US18053582

申请日：2022-11-08

Applicant: H. Lundbeck A/S ,  THE SCRIPPS RESEARCH INSTITUTE

Inventor： Justin S. CISAR ,  Cheryl A. GRICE ,  Todd K. JONES ,  Micah J. NIPHAKIS ,  Jae Won CHANG ,  Kenneth M. LUM ,  Benjamin F. CRAVATT

IPC: C07D295/205 ,  C07C271/12 ,  C07D317/46 ,  C07D317/58 ,  C07D231/12 ,  C07D231/16 ,  C07D231/56 ,  C07D241/04 ,  C07D471/04 ,  C07D471/10 ,  C07D261/08 ,  C07D487/04 ,  C07D263/32 ,  C07D205/04 ,  C07D491/107 ,  C07D207/14 ,  C07D271/06 ,  C07D307/79 ,  C07D405/14 ,  C07D215/42 ,  C07D213/40 ,  A61P25/22 ,  C07D295/26 ,  C07D213/55 ,  C07D401/04 ,  C07D407/06 ,  C07D413/06 ,  C07C271/10 ,  C07D207/09 ,  C07D213/38 ,  C07D215/46 ,  C07D401/10 ,  C07D403/10 ,  C07D413/10

CPC classification number: C07D295/205 ,  C07C271/12 ,  C07D317/46 ,  C07D317/58 ,  C07D231/12 ,  C07D231/16 ,  C07D231/56 ,  C07D241/04 ,  C07D471/04 ,  C07D471/10 ,  C07D261/08 ,  C07D487/04 ,  C07D263/32 ,  C07D205/04 ,  C07D491/107 ,  C07D207/14 ,  C07D271/06 ,  C07D307/79 ,  C07D405/14 ,  C07D215/42 ,  C07D213/40 ,  A61P25/22 ,  C07D295/26 ,  C07D213/55 ,  C07D401/04 ,  C07D407/06 ,  C07D413/06 ,  C07C271/10 ,  C07D207/09 ,  C07D213/38 ,  C07D215/46 ,  C07D401/10 ,  C07D403/10 ,  C07D413/10

Abstract: This disclosure provides compounds and compositions which may be modulators of MAGL and/or ABHD6 and their use as medicinal agents, processes for their preparation, and pharmaceutical compositions that include disclosed compounds as at least one active agent. The disclosure also provides for method of treating a patient in need thereof, where the patient is suffering from post-traumatic stress disorder comprising administering a disclosed compound or composition.

公开(公告)号：US20220235037A1

公开(公告)日：2022-07-28

申请号：US17469535

申请日：2021-09-08

Applicant: H. Lundbeck A/S

Inventor： Cheryl A. GRICE ,  Todd K. JONES ,  Kurt G. GRIMM ,  Jacqueline Lorayne BLANKMAN ,  Channing Rodney BEALS

IPC: C07D403/10

Abstract: Described herein is the MAGL inhibitor 1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate, including crystalline forms and pharmaceutically acceptable salts and solvates thereof.

公开(公告)号：US20210230145A1

公开(公告)日：2021-07-29

申请号：US17227072

申请日：2021-04-09

Applicant: H. Lundbeck A/S

Inventor： Jacqueline Lorayne BLANKMAN ,  Jason Robert CLAPPER ,  R. Alan B. EZEKOWITZ ,  Iain Peter FRASER ,  Cheryl A. GRICE ,  Todd K. JONES ,  Gary Paul O'NEILL ,  Archie Wayne THURSTON, JR. ,  Channing Rodney BEALS

IPC: C07D403/10 ,  A61K31/495 ,  C07D295/205 ,  A61P29/00

Abstract: Provided herein are methods of treating inflammation or neuropathic pain using an effective dose of a monoacylglycerol lipase inhibitor or a composition thereof.